Dashboard
Manage Tickers

ELDNEledon Pharmaceuticals, Inc.


$ 3.09 $ 0.10 (3.31 %)    

Monday, 20-May-2024 15:56:38 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 454.82 $ 3.15 (0.7 %)
DIA $ 398.57 $ -1.85 (-0.46 %)
SPY $ 530.36 $ 0.61 (0.12 %)
TLT $ 91.26 $ -0.27 (-0.3 %)
GLD $ 225.37 $ 0.90 (0.4 %)
$ na
$ 3.24
$ 0.00 x 0
$ 3.12 x 250
$ 3.05 - $ 3.30
$ 1.07 - $ 3.35
360,583
na
93.57M
$ 0.26
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

12-health-care-stocks-moving-in-fridays-after-market-session
12 Health Care Stocks Moving In Friday's A...
05/17/2024 20:31:00

hc-wainwright--co-reiterates-buy-on-eledon-pharma-maintains-16-price-target
HC Wainwright & Co. Reiterates Buy on Eled...
05/10/2024 19:26:57

HC Wainwright & Co. analyst Vernon Bernardino reiterates Eledon Pharma (NASDAQ:ELDN) with a Buy and maintains $16 price ...

eledon-pharma-q1-2024-gaap-eps-034-beats-039-estimate
Eledon Pharma Q1 2024 GAAP EPS $(0.34) Bea...
05/09/2024 12:13:59

Eledon Pharma (NASDAQ:ELDN) reported quarterly losses of $(0.34) per share which beat the analyst consensus estimate of $(0.39)...

nano-cap-eledon-pharmaceuticals-investigational-drug-shows-safety-in-early-organ-transplant-study-analyst-boosts-forecast-on-increased-confidence
Nano-Cap Eledon Pharmaceuticals' Investiga...
05/07/2024 19:40:23

Eledon Pharmaceuticals' results from islet cell transplant trial for type 1 diabetes, with tegoprubart showing safety and e...

hc-wainwright--co-maintains-buy-on-eledon-pharma-raises-price-target-to-16
HC Wainwright & Co. Maintains Buy on Eledo...
05/07/2024 14:16:19

HC Wainwright & Co. analyst Vernon Bernardino maintains Eledon Pharma (NASDAQ:ELDN) with a Buy and raises the price targ...

12-health-care-stocks-moving-in-tuesdays-pre-market-session
12 Health Care Stocks Moving In Tuesday's ...
05/07/2024 12:06:20

eledon-pharmaceuticals-announced-a-private-investment-of-approximately-50m-with-sale-of-131m-shares-at-237share-and-pre-funded-warrants-at-2369underlying-share-which-are-exercisable-to-purchase-799m-shares
Eledon Pharmaceuticals Announced A Private...
05/07/2024 11:23:50

eledon-announces-clinical-progress-with-tegoprubart-in-the-prevention-of-transplant-rejection-in-patients-with-type-1-diabetes
Eledon Announces Clinical Progress With Te...
05/07/2024 11:21:38

First participant dosed in clinical trial at University of Chicago Medicine assessing the use of tegoprubart to prevent islet...

Core News & Articles
Watching Eledon Pharmaceuticals, Acumen Ph...
04/18/2024 15:41:59

https://blog.tipranks.com/these-2-strong-buy-penny-stocks-are-poised-for-over-300-gains-say-analysts/  

eledon-pharma-q4-2023-gaap-eps-032-beats-039-estimate
Eledon Pharma Q4 2023 GAAP EPS $(0.32) Bea...
03/28/2024 20:07:10

Eledon Pharma (NASDAQ:ELDN) reported quarterly losses of $(0.32) per share which beat the analyst consensus estimate of $(0.39)...

eledon-pharmaceuticals-reports-12th-participant-enrolled-in-phase-2-bestow-trial-evaluating-tegoprubart-for-prevention-of-organ-rejection
Eledon Pharmaceuticals Reports 12th Partic...
03/25/2024 20:58:05

hc-wainwright--co-reiterates-buy-on-eledon-pharma-maintains-13-price-target
HC Wainwright & Co. Reiterates Buy on Eled...
03/22/2024 10:35:26

HC Wainwright & Co. analyst Vernon Bernardino reiterates Eledon Pharma (NASDAQ:ELDN) with a Buy and maintains $13 price ...

kidney-transplant-from-genetically-edited-pig-boston-patient-with-end-stage-renal-disease-becomes-first-to-receive
Kidney Transplant From Genetically Edited ...
03/21/2024 18:35:57

Eledon Pharmaceuticals announces successful use of tegoprubart in kidney xenotransplant. Promising results show its potential t...

eledon-pharmaceuticals-announces-use-of-tegoprubart-in-first-ever-transplant-of-genetically-modified-kidney-from-a-pig-to-a-human
Eledon Pharmaceuticals Announces Use Of Te...
03/21/2024 14:31:59

Historic kidney xenotransplantation procedure conducted at Massachusetts General HospitalTegoprubart administration has now bee...

eledon-pharmaceuticals-provides-guidance-for-anticipated-upcoming-2024-milestones
Eledon Pharmaceuticals Provides Guidance F...
01/04/2024 21:44:05

Anticipated 2024 Milestones:  First half of 2024: Report updated interim clinical data from the ongoing Phase 1b trial of te...

expert-ratings-for-eledon-pharma
Expert Ratings for Eledon Pharma
11/13/2023 15:00:19

hc-wainwright--co-reiterates-buy-on-eledon-pharma-maintains-13-price-target
HC Wainwright & Co. Reiterates Buy on Eled...
11/13/2023 12:47:24

HC Wainwright & Co. analyst Vernon Bernardino reiterates Eledon Pharma (NASDAQ:ELDN) with a Buy and maintains $13 price ...

eledon-pharma-q3-eps-035-beats-050-estimate
Eledon Pharma Q3 EPS $(0.35) Beats $(0.50)...
11/09/2023 21:52:00

Eledon Pharma (NASDAQ:ELDN) reported quarterly losses of $(0.35) per share which beat the analyst consensus estimate of $(0.50)...

eledon-reports-updated-data-from-ongoing-phase-1b-trial-evaluating-tegoprubart-for-prevention-of-rejection-in-kidney-transplantation
Eledon Reports Updated Data From Ongoing P...
11/02/2023 13:22:42

Data from 11 participants demonstrates tegoprubart successfully prevented kidney transplant rejection and was generally safe an...

hc-wainwright--co-maintains-buy-on-eledon-pharma-lowers-price-target-to-13
HC Wainwright & Co. Maintains Buy on Eledo...
10/24/2023 11:04:32

HC Wainwright & Co. analyst Vernon Bernardino maintains Eledon Pharma (NASDAQ:ELDN) with a Buy and lowers the price targ...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION